210 related articles for article (PubMed ID: 28762200)
1. Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation.
Gast K; Schüler A; Wolff M; Thalhammer A; Berchtold H; Nagel N; Lenherr G; Hauck G; Seckler R
Pharm Res; 2017 Nov; 34(11):2270-2286. PubMed ID: 28762200
[TBL] [Abstract][Full Text] [Related]
2. Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.
Teska BM; Alarcón J; Pettis RJ; Randolph TW; Carpenter JF
J Pharm Sci; 2014 Aug; 103(8):2255-67. PubMed ID: 24909933
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart.
Havelund S; Ribel U; Hubálek F; Hoeg-Jensen T; Wahlund PO; Jonassen I
Pharm Res; 2015 Jul; 32(7):2250-8. PubMed ID: 25563978
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic fibrillation of fast-acting insulin analogs.
Woods RJ; Alarcón J; McVey E; Pettis RJ
J Diabetes Sci Technol; 2012 Mar; 6(2):265-76. PubMed ID: 22538135
[TBL] [Abstract][Full Text] [Related]
5. Concentration and Chemical Stability of Commercially Available Insulins: A High-Resolution Mass Spectrometry Study.
Baechler F; Stettler C; Vogt B; Bally L; Groessl M
Diabetes Technol Ther; 2020 Apr; 22(4):326-329. PubMed ID: 32031881
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine.
Bode BW
Endocr Pract; 2011; 17(2):271-80. PubMed ID: 21134878
[TBL] [Abstract][Full Text] [Related]
7. Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects.
Becker RH; Frick AD; Burger F; Potgieter JH; Scholtz H
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):435-43. PubMed ID: 16151977
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
Roach P; Woodworth JR
Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
[TBL] [Abstract][Full Text] [Related]
9. Assembly and dissociation of human insulin and LysB28ProB29-insulin hexamers: a comparison study.
Birnbaum DT; Kilcomons MA; DeFelippis MR; Beals JM
Pharm Res; 1997 Jan; 14(1):25-36. PubMed ID: 9034217
[TBL] [Abstract][Full Text] [Related]
10. Profiling Insulin Oligomeric States by
Falk BT; Liang Y; McCoy MA
J Pharm Sci; 2020 Jan; 109(1):922-926. PubMed ID: 31449814
[TBL] [Abstract][Full Text] [Related]
11. Role of ultrafast-acting insulin analogues in the management of diabetes.
Kruger DF; Novak LM
J Am Assoc Nurse Pract; 2019 Sep; 31(9):537-548. PubMed ID: 31385938
[TBL] [Abstract][Full Text] [Related]
12. Ultra-rapid absorption of recombinant human insulin induced by zinc chelation and surface charge masking.
Pohl R; Hauser R; Li M; De Souza E; Feldstein R; Seibert R; Ozhan K; Kashyap N; Steiner S
J Diabetes Sci Technol; 2012 Jul; 6(4):755-63. PubMed ID: 22920799
[TBL] [Abstract][Full Text] [Related]
13. Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.
da Silva DC; Lima LMTR
Int J Pharm; 2018 Aug; 547(1-2):621-629. PubMed ID: 29928940
[TBL] [Abstract][Full Text] [Related]
14. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
15. [From the concept of fast acting analogs to the properties of the insulin Lispro].
Selam JL
Diabetes Metab; 1997 Sep; 23 Suppl 3():45-9. PubMed ID: 9410552
[TBL] [Abstract][Full Text] [Related]
16. Insulin lispro: its role in the treatment of diabetes mellitus.
Campbell RK; Campbell LK; White JR
Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
[TBL] [Abstract][Full Text] [Related]
17. Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site.
Khadria A; Paavola CD; Maslov K; Valenzuela FA; Sperry AE; Cox AL; Cao R; Shi J; Brown-Augsburger PL; Lozano E; Blankenship RL; Majumdar R; Bradley SA; Beals JM; Oladipupo SS; Wang LV
Mol Metab; 2022 Aug; 62():101522. PubMed ID: 35671972
[TBL] [Abstract][Full Text] [Related]
18. The quaternary structure of insulin glargine and glulisine under formulation conditions.
Nagel N; Graewert MA; Gao M; Heyse W; Jeffries CM; Svergun D; Berchtold H
Biophys Chem; 2019 Oct; 253():106226. PubMed ID: 31376619
[TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive polyelectrolyte microparticles containing recombinant human insulin and its analogs aspart and lispro.
Balabushevich NG; Pechenkin MA; Zorov IN; Shibanova ED; Larionova NI
Biochemistry (Mosc); 2011 Mar; 76(3):327-31. PubMed ID: 21568867
[TBL] [Abstract][Full Text] [Related]
20. Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues.
Kamal AD; Bain SC
Expert Opin Drug Saf; 2007 Jan; 6(1):5-7. PubMed ID: 17181446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
